Literature DB >> 26547055

Multicomponent assembly of 4-aza-podophyllotoxins: A fast entry to highly selective and potent anti-leukemic agents.

Nagalakshmi Jeedimalla1, Madison Flint1, Lyndsay Smith2, Alberto Haces1, Dmitriy Minond3, Stéphane P Roche4.   

Abstract

The aim of this study was the synthesis and lead structure selection of a best anti-leukemic agent from a library of aza-podophyllotoxin analogues (APTs). To this end, we report a scalable, modified multicomponent reaction using a "sacrificial" aniline partner as a more general route to rapidly construct the pivotal library of 50 APT analogues. Our preliminary structure activity relationship studies for anti-leukemic activity also address the innate toxicity of these compounds against non-malignant cells. As a result, we identified 2 novel compounds 2ca' and 2jc' more potent than etoposide 1 (25-60 fold) having high selectivity against the human THP-1 leukemia cell line and a minimal toxicity (IC50 of 9.3 ± 0.8 and 19.6 ± 1.4 nM respectively) which represent the best candidates for further pharmacological optimization. Published by Elsevier Masson SAS.

Entities:  

Keywords:  AML; Anti-leukemic agents; Aza-podophyllotoxins; Etoposide; Multicomponent reactions; SAR study

Mesh:

Substances:

Year:  2015        PMID: 26547055     DOI: 10.1016/j.ejmech.2015.10.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Intercepted-Knoevenagel condensation for the synthesis of unsymmetrical fused-tricyclic 4H-pyrans.

Authors:  Charles Shearer; Oriane Desaunay; Stephen Zorc; Alexis D Richaud; Shyam S Samanta; Nagalakshmi Jeedimalla; Stéphane P Roche
Journal:  Tetrahedron       Date:  2019-09-17       Impact factor: 2.457

2.  Synthesis and biological activity, and molecular modelling studies of potent cytotoxic podophyllotoxin-naphthoquinone compounds.

Authors:  Ha Thanh Nguyen; Quynh Giang Nguyen Thi; Thu Ha Nguyen Thi; Phuong Hoang Thi; Giang Le-Nhat-Thuy; Tuyet Anh Dang Thi; Bao Le-Quang; Hai Pham-The; Tuyen Van Nguyen
Journal:  RSC Adv       Date:  2022-08-09       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.